Thermo Fisher Scientific Opens New Manufacturing Facility in China

Expands Global Footprint, Local Production Capabilities to Address Increased Demand from Life Sciences Customers in China and Asia-Pacific Region

Thursday, November 15, 2012 10:00 pm EST

Dateline:

WALTHAM, Mass.

Public Company Information:

NYSE:
TMO
"China is one of our fastest-growing markets and has been a key contributor to our success"

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.

Since entering the Chinese market 30 years ago, Thermo Fisher Scientific has established a strong research and development, manufacturing and commercial infrastructure in China, becoming one of the largest companies serving the life sciences market in the region. Most recently, Thermo Fisher has invested nearly $20 million in the 12,000-square-meter Suzhou plant, which will house more than 150 employees and has room for expansion. From this geographically central location, the new facility will primarily serve the life sciences and pharmaceutical industries, including research, diagnostics and bioproduction, as well as customers in the chemical, environmental and electronics industries.

In Suzhou, Thermo Fisher will manufacture plastic labware and consumables, including sample preparation products and filterware, as well as laboratory refrigerators, freezers, incubators and centrifuges. To ensure an environmentally friendly and safe work environment, the new facility will follow the best global and local manufacturing practices, including ISO9001, ISO14001 and ISO13485 standards.

“China is one of our fastest-growing markets and has been a key contributor to our success,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The Suzhou facility builds on our well-established presence in China and is an important next step as we closely align our depth of capabilities with China’s five-year plan to develop strategic industries, including pharmaceutical, healthcare and environmental.”

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.

Contact:

Thermo Fisher Scientific
Media Contact:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
Website: www.thermofisher.com
or
Investor Contact:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

Thermo Fisher Tweets

Introducing the first NGS-based IVD test for detection of genetic mutations in #NSCLC - Oncomine Dx Target Test… https://t.co/jR0BLLcoT0-3 hours 36 min ago
Hi, Can you plz share serial # of your Vanquish system & your location? We can connect you with the right team. Thanks.-7 hours 25 min ago
Scientists will do just about anything to get an automated cell counter! https://t.co/iWeiF2rvuX See the rebellion. https://t.co/8d3TauNecG-7 hours 57 min ago
What’s the advantage of exceptionally bright readouts for better discrimination of cell subpopulations?… https://t.co/0LbS3hM38m-7 hours 57 min ago
We've just received FDA approval for the first NGS-based IVD test for detection of genetic mutations in #NSCLC https://t.co/uXlmLlmTq1-1 day 1 hour ago